The Health Care Costs of Heart Failure in Sweden
Overview
Authors
Affiliations
Aim: Heart failure is a common and serious condition requiring extensive health care resources. The aim of this study is to estimate the total treatment costs of heart failure in Sweden.
Methods And Results: The study is a prevalence-based cost-of-illness study. It includes costs of institutional care (hospitals and nursing homes), outpatient care, surgery and drugs. The costs are estimated based on official Swedish statistics, and on various clinical and epidemiological studies. The results are expressed in 1996 prices. The total annual treatment costs for heart failure are approximately Swedish kronor (SEK) 2000-2600 million, or nearly 2% of the Swedish health care budget. Institutional care is the single largest component, amounting to SEK 1300-1900 million, or about 65-75% of the costs of heart failure treatment.
Conclusions: The results from this study indicate that heart failure is a costly condition. Efforts to develop effective management programmes that can reduce the need for expensive institutional care, without a negative impact on quality of life, morbidity and mortality, should be given high priority.
Heart failure in Nigeria: protocol for a systematic review and meta-analysis.
Ogah O, Kushimo O, Adebiyi A, Onyema C, Uchenna O, Adebayo B Afr Health Sci. 2024; 23(2):530-536.
PMID: 38223635 PMC: 10782286. DOI: 10.4314/ahs.v23i2.61.
Boman K, Lindmark K, Stalhammar J, Olofsson M, Costa-Scharplatz M, Fonseca A BMJ Open. 2021; 11(10):e053806.
PMID: 34667015 PMC: 8527145. DOI: 10.1136/bmjopen-2021-053806.
Healthcare Expenditures Associated with Heart Failure in Saudi Arabia: A Cost of Illness Study.
Alghamdi A, Algarni E, Balkhi B, Altowaijri A, Alhossan A Healthcare (Basel). 2021; 9(8).
PMID: 34442125 PMC: 8391138. DOI: 10.3390/healthcare9080988.
Wideqvist M, Cui X, Magnusson C, Schaufelberger M, Fu M ESC Heart Fail. 2021; 8(2):1388-1397.
PMID: 33599109 PMC: 8006673. DOI: 10.1002/ehf2.13221.
From bedside to bench: lung ultrasound for the assessment of pulmonary edema in animal models.
Grune J, Beyhoff N, Hegemann N, Lauryn J, Kuebler W Cell Tissue Res. 2020; 380(2):379-392.
PMID: 32009189 PMC: 7210222. DOI: 10.1007/s00441-020-03172-2.